Patent 10377760 was granted and assigned to FORMA Therapeutics on August, 2019 by the United States Patent and Trademark Office.
The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: